Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bon Health vs NextMeds

Bon Health
Graded #113

Higher grade

vs+3.4000000000000057
NextMeds
Graded #191

Lower grade

The verdict

Bon Health takes it — 69.7/100 to 66.3/100.

Bon Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bon Health is a physician-led GLP-1 weight-loss telehealth service selling compounded semaglutide and tirzepatide on commitment tiers.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueBon Health +19
75
56
Dose & formulationEven
64
64
Clinical oversightBon Health +8
85
77
Labs & monitoringNextMeds +6
55
61
FulfillmentNextMeds +12
72
84
Contract termsNextMeds +8
53
61
Bon Health · left barNextMeds · right bar

The numbers

MetricBon HealthNextMeds
WeighScore69.7/10066.3/100
GradeCC
Scorecard rank#113#191
Semaglutide$120/mo (12-month plan, compounded)$129/mo (plus a separate fee, compounded)
Tirzepatide$170/mo (12-month plan, compounded)$179/mo (plus a separate fee, compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Bon Health

Graded #113 · C

Strengths

  • Transparent commitment-tier pricing from $170/mo (annual) for compounded semaglutide and tirzepatide; $0 membership fee, cancel anytime
  • Physician-led: comprehensive medical review and physician-titrated dosing, not a 2-minute quiz
  • 24/7 physician support included free with your order; 1-3 day rapid dispatch
  • Licensed in all 50 states; uses 503A & 503B compounding pharmacies; brand-name Wegovy/Ozempic/Zepbound/Mounjaro also offered

Where it loses points

  • The advertised rates need a full year paid up front; billed monthly, semaglutide is $230 and the annual figure nearly doubles
  • The brand-name pages are marketing, not products — every Wegovy, Ozempic, Zepbound and Mounjaro CTA reads 'Coming Soon' and points back to the compounded version
  • Coverage is not published: a badge claims all 50 states while the weight-loss page says availability varies by state
  • The terms page returns a 404, so the refund mechanics behind the prepaid 3-, 6- and 12-month tiers cannot be read
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
NextMeds

Graded #191 · C

Strengths

  • Flat monthly membership bundles the medication, telehealth visits, a 1:1 care coach and a licensed registered dietitian — one price, no hidden fees
  • Same price every dose, no auto-renewal, cancel anytime; free shipping and no insurance needed (FSA eligible)
  • Names a compounding pharmacy partner (Foothills Pharmacy) and states it services all 50 states
  • Free, no-obligation online assessment before you pay anything

Where it loses points

  • Shows a LegitScript 'approval' but links only a generic directory search, not a verifiable seal — we couldn't independently confirm it
  • Promo-driven pricing with a countdown timer and 'price increases' urgency; the standing membership is $129 (sema) / $179 (tirz)
  • A technology platform that coordinates care, not the medical provider; individual clinicians and a medical director aren't named on the site
  • Compounded semaglutide and tirzepatide only — no brand-name (Wegovy/Zepbound) options
  • Compounded GLP-1s are not FDA-reviewed or approved — a different evidence and regulatory tier than brand-name

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard